Menu
Search
|

Menu

Close
X

LeMaitre Vascular Inc LMAT.OQ (NASDAQ Stock Exchange Global Market)

27.58 USD
+0.07 (+0.25%)
As of Nov 16
chart
Previous Close 27.51
Open 26.87
Volume 52,073
3m Avg Volume 45,850
Today’s High 27.75
Today’s Low 26.87
52 Week High 41.23
52 Week Low 25.67
Shares Outstanding (mil) 19.58
Market Capitalization (mil) 518.34
Forward P/E 26.27
Dividend (Yield %) 0.07 ( 1.06 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.86 Mean rating from 7 analysts

KEY STATS

Revenue (mm, USD)
FY18
77
FY17
101
FY16
89
FY15
78
EPS (USD)
FY18
0.816
FY17
0.838
FY16
0.552
FY15
0.418
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
26.27
29.34
Price to Sales (TTM)
vs sector
5.02
20.58
Price to Book (MRQ)
vs sector
4.14
4.23
Price to Cash Flow (TTM)
vs sector
21.07
21.19
Total Debt to Equity (MRQ)
vs sector
0.00
13.84
LT Debt to Equity (MRQ)
vs sector
0.00
9.93
Return on Investment (TTM)
vs sector
17.08
13.58
Return on Equity (TTM)
vs sector
17.63
15.11

EXECUTIVE LEADERSHIP

George LeMaitre
Chairman of the Board, Chief Executive Officer, Since 2007
Salary: $162,392.00
Bonus: --
David Roberts
President, Director, Since 2007
Salary: $339,102.00
Bonus: $122,732.00
Joseph Pellegrino
Chief Financial Officer, Director, Since 2016
Salary: $283,041.00
Bonus: $114,452.00
Trent Kamke
Senior Vice President - Operations, Since 2005
Salary: $214,141.00
Bonus: $85,000.00
Lawrence Jasinski
Independent Director, Since 2003
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

63 2nd Ave
BURLINGTON   MA   01803-4413

Phone: +1781.2212266

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

SPONSORED STORIES